NCT04231708 Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder Status NOT_YET_RECRUITING Phase PHASE2
NCT04212065 Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women Status WITHDRAWN Phase PHASE4
NCT04208217 Participatory System Dynamics vs Usual Quality Improvement: Staff Use of Simulation as an Effective, Scalable and Affordable Way to Improve Timely Mental Health Care? Status COMPLETED Phase NA
NCT04161066 Adjunctive Effects of Psilocybin and a Formulation of Buprenorphine Status RECRUITING Phase PHASE1
NCT03958474 Neurobehavioral Mechanisms of Choice in Opioid Use Disorder Status COMPLETED Phase EARLY_PHASE1
NCT03944850 Computerized Anxiety Sensitivity Treatment for Opioid Use Disorders Status COMPLETED Phase NA
NCT03842384 Digital Health Intervention to Support Opioid Use Disorder Treatment Status COMPLETED Phase NA
NCT03821337 Transcranial Magnetic Stimulation (rTMS) as a Tool to Decrease Pain and Improve Functioning Status TERMINATED Phase NA
NCT03810495 The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03389750 A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists. Status COMPLETED Phase PHASE2
NCT03248947 Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075 Status COMPLETED Phase EARLY_PHASE1
NCT03151655 Changing Opioid Users' Negative Attitudes Toward Medication Assisted Treatment Status WITHDRAWN Phase NA
NCT03033732 A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse Status COMPLETED Phase PHASE4